garyc

Fixing Pfizer

I have owned shares in gnbt for the past five years and I think it is a worthwhile effort to develop a form of insulin delivery other than the NEEDLE. Also I have bought and sold gnbt several times and made some money each time. That can't be to bad!

Generex Biotechnology: Oral-lyn Buccal Insulin Takes Center Stage

I think this article has really put the emphasis on what the GNBT team has been developing and that it would be extremely helpful for the Diabetic Patient. If the news and opinions such as this article could find a place in the mainstream news, I think you would see the stock price react positively. All other indicators for a large increase at the ticker are there, they just need to be more in the news about what they are doing. The rest will come!